Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/11/2003US6531283 Protein expression profiling
03/11/2003US6531280 Method for identifying or isolating a molecule and molecules identified thereby
03/11/2003US6531278 Ligand-DNA composition for capture and detection of contaminants on a solid surface
03/11/2003US6531277 Endometriosis-specific secretory protein
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531136 Equine rhinovirus 1 proteins
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003US6531040 Electrochemical-sensor design
03/11/2003US6530871 Centrifuge having a bag arrangement and a method for operating the centrifuge
03/11/2003US6530287 Alpha-environmental continuous air monitor inlet
03/11/2003CA2099543C Photochemical labelling of nucleic acids with digoxigenin reagents and their use in gene probe test systems
03/07/2003WO2002021122A1 Method and apparatus for continuous fractional analysis of metallic mercury and water-soluble mercury in a gas
03/07/2003CA2399169A1 Diagnostic methods for determining susceptibility to convulsive conditions
03/06/2003WO2003019981A2 Electromagnetic piezoelectric acoustic sensor
03/06/2003WO2003019451A1 A method and system for defining gene hunting studies
03/06/2003WO2003019331A2 Method of conducting and documenting analyte screening tests
03/06/2003WO2003019230A1 Measurement of air characteristics in the lower atmosphere
03/06/2003WO2003019199A1 Substrate having ligands immobilized thereon
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019197A2 Diabetic model
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003019195A2 Cellular immunity test with peptides fixed on a solid support
03/06/2003WO2003019193A1 Method of diagnosing nephrotic syndrome
03/06/2003WO2003019192A1 Apparatus, composition and method for proteome profiling
03/06/2003WO2003019190A1 Method for detecting in/vitro food antigen intolerance
03/06/2003WO2003019188A1 Methdo and arrangement for analyzing substances
03/06/2003WO2003019187A1 Method of selecting binding molecule
03/06/2003WO2003019186A2 Assay for identifying ion channel modulators
03/06/2003WO2003019184A1 Biometric quality control process
03/06/2003WO2003019183A1 Process for the informative and iterative design of a gene-family screening library
03/06/2003WO2003019182A1 Method for producing microparticles loaded with proteins
03/06/2003WO2003019181A2 Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
03/06/2003WO2003019179A1 Fluorescence based oxygen sensor systems
03/06/2003WO2003019178A2 Method and apparatus for testing aldehyde in a polyester polymer
03/06/2003WO2003019176A2 Method and apparatus for determination of water and for normal phase liquid chromatography
03/06/2003WO2003019171A1 Methods for producing highly sensitive potentiometric sensors
03/06/2003WO2003019166A1 System and method for blood analysis
03/06/2003WO2003019165A2 Method and apparatus for calibrating electrochemical sensors
03/06/2003WO2003019157A1 High throughput mechanical rapid serial property testing of materials libraries
03/06/2003WO2003019155A1 Method of analyzing interaction between material and biological substance
03/06/2003WO2003019151A1 Method and device for measuring the viscosity of a liquid
03/06/2003WO2003019147A2 Enzyme-amplified redox microarray detection process
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003019145A2 Non-fluorescent quencher compounds and biomolecular assays
03/06/2003WO2003019144A2 METHODS AND COMPOSITIONS FOR SCREENING, DIAGNOSING, OR TREATING NF-λB RELATED DISEASE
03/06/2003WO2003019142A2 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
03/06/2003WO2003019141A2 Analysis of circulating tumor cells, fragments, and debris
03/06/2003WO2003019140A2 Method for molecular subshape similarity matching
03/06/2003WO2003019138A2 Bio-sensing platforms for detection and quantitation of biological molecules
03/06/2003WO2003019136A2 Methods for inhibiting angiogenesis
03/06/2003WO2003019135A2 Reference control for high-sensitivity c-reactive protein testing
03/06/2003WO2003019134A2 Immunoassays using an azlactone-modified polymeric substrate
03/06/2003WO2003019119A1 Combined fluid condition monitor and fluid level sensor
03/06/2003WO2003019105A1 Device and method for identifying metal body
03/06/2003WO2003018854A2 Immobilization of biological molecules onto surfaces coated with monolayers
03/06/2003WO2003018846A1 Affinity tag modified particles
03/06/2003WO2003018844A1 Method and apparatus for three label microarrays
03/06/2003WO2003018842A1 Novel gene nedl-1
03/06/2003WO2003018838A2 Interaction detection on several probe arrays
03/06/2003WO2003018837A2 Method and diagnostic kit for the molecular diagnosis of pharmacologically relevant genes
03/06/2003WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease
03/06/2003WO2003018830A2 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
03/06/2003WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018812A1 Regulation of human ptpase-like protein
03/06/2003WO2003018807A1 Nucleic acids showing difference in expression between hepatoblastoma anc normal liver
03/06/2003WO2003018804A1 Proteins having effects of controlling cell migration and cell death
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018801A1 Cd36/fat gene promoter and diagnosis of disease associated with cd36/fat gene
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018797A2 Method and device for integrated protein expression, purification and detection
03/06/2003WO2003018791A1 Method of detecting toxic substance
03/06/2003WO2003018781A1 Regulation of cytotrophoblast cell differentiation and cell migration
03/06/2003WO2003018776A2 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS
03/06/2003WO2003018775A2 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
03/06/2003WO2003018770A2 Amplified oncogenes and their involvement in cancer
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018760A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
03/06/2003WO2003018757A2 Stabilization of cells and biological specimens for analysis
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018755A2 Wild-type ras as a cancer therapeutic agent
03/06/2003WO2003018753A2 Multiple-site sample-handling apparatus and method
03/06/2003WO2003018752A2 An organotypic intestinal culture and methods of use thereof
03/06/2003WO2003018741A1 Coagulation assay reagents containing lanthanides and a protein c assay using such a lanthanide-containing reagent
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018633A1 Prion capture
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018610A2 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
03/06/2003WO2003018609A2 Application of peptide conjugates to alzheimer's disease
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018068A1 Ocular diagnosis of alzheimer's disease
03/06/2003WO2003018066A2 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
03/06/2003WO2003018058A1 Myocardial cell apoptosis inhibitors
1 ... 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 ... 3937